Heterozygous loss of TSC2 alters p53 signaling and human stem cell reprogramming

Laura C Armstrong1, Grant Westlake1, John P Snow1

  • 1Division of Pediatric Neurology, Department of Pediatrics, Vanderbilt University Medical Center, D4105 Medical Center North, Nashville, TN 37232, USA.

Human Molecular Genetics
|October 4, 2017
PubMed

Insights

Tuberous sclerosis complex (TSC) involves gene mutations affecting cell growth. This study found that TSC2 gene variations increase p53 levels, impacting stem cell reprogramming and TSC development.

Area of Science:

  • Genetics
  • Developmental Biology
  • Cell Biology

Background:

  • Tuberous sclerosis complex (TSC) is a pediatric genetic disorder characterized by abnormal cell growth and differentiation.
  • TSC results from loss-of-function mutations in TSC1 or TSC2 genes, which are critical regulators of mTOR kinase activity.
  • Understanding early developmental aberrations in TSC is crucial for therapeutic strategies.

Purpose of the Study:

  • To investigate the role of TSC2 and p53 interactions in the pathogenesis of Tuberous Sclerosis Complex.
  • To analyze stem cell reprogramming efficiency in TSC patient-derived cells.
  • To determine the impact of TSC2 gene dosage on p53 levels and cellular reprogramming.

Main Methods:

  • Generation of induced pluripotent stem cells (iPSCs) from dermal fibroblasts of TSC patients.
  • Assessment of reprogramming plasmid integration rates in TSC-derived stem cells.
  • Quantification of p53 protein levels in human fibroblasts and stem cells with varying TSC2 genotypes (heterozygous and homozygous mutants).

Main Results:

  • Stem cells derived from TSC patients exhibited a high rate of reprogramming plasmid integration, including shRNA targeting TP53.
  • Loss of a single TSC2 allele in human fibroblasts was sufficient to elevate p53 levels and hinder stem cell reprogramming.
  • Elevated p53 levels were consistently observed in TSC2 heterozygous and homozygous mutant human stem cells, indicating conserved TSC2-p53 interactions.

Conclusions:

  • TSC2 heterozygous and homozygous mutant cells significantly contribute to the pathogenesis of Tuberous Sclerosis Complex.
  • The p53 pathway plays a critical role during the stem cell reprogramming process in the context of TSC.
  • The interaction between TSC2 and p53 is consistent across different cell types and gene dosage, highlighting its importance in TSC.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.7K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K